ReviewCanadian journal of gastroenterology = Journal canadien de gastroenterologie2007
The myths and realities of hemochromatosis.
Review in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 28 citations in OpenAlex.
- Article
- A Dual-Responsive 1,3,4-Oxadiazole-Linked Bis-Indole Fluorescent Chemosensor for the Selective Detection of TNP and Iron Ions.Journal of fluorescence · 2026Article
- Potential Correlation between Kienböck's Disease and Hereditary Hemochromatosis: A Case Report.Journal of orthopaedic case reports · 2024Article
- Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot Study.Diagnostics (Basel, Switzerland) · 2021Article
- Article
- Polycythemia in Patients With Hereditary Hemochromatosis: Real or Myth?Journal of clinical medicine research · 2019Article
- Dietary and Sentinel Factors Leading to Hemochromatosis.Nutrients · 2019Review
- Iron and Sex Cross Paths in the Heart.Journal of the American Heart Association · 2017Article
- Subjects At-Risk for Genetic Diseases in Portugal: Illness Representations.Journal of genetic counseling · 2016Article
- A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.Hepatology (Baltimore, Md.) · 2010Article
- Manganese (Mn) and iron (Fe): interdependency of transport and regulation.Neurotoxicity research · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemochromatosis is a common genetic condition and yet there are still a number of misperceptions surrounding the diagnosis and management of this condition. Hemochromatosis affects both men and women. Typical patients do not have alcoholism or viral hepatitis, and often have normal liver enzymes. Clinical expression is highly variable. Genetic testing is widely available and particularly useful in family studies. Hemochromatosis can be readily diagnosed and treated. The purpose of the present review is to address the medical myths and misconceptions of hemochromatosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.